# Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

> **NCT01523652** · — · COMPLETED · sponsor: **Azienda Ospedaliera San Giovanni Battista** · enrollment: 29 (actual)

## Conditions studied

- Genital Diseases, Female
- Ovarian Neoplasms
- Urogenital Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01523652
- **Lead sponsor:** Azienda Ospedaliera San Giovanni Battista
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523652, "Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01523652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*